Peptide-Loaded Nanoparticles

Therapeutic peptides face significant pharmacokinetic limitations including rapid renal clearance, susceptibility to serum proteases, and poor membrane permeability. Encapsulation within nanoparticle delivery systems addresses these challenges by protecting peptide cargo from degradation and enabling controlled release kinetics.

Polymeric Nanoparticles

PLGA (poly(lactic-co-glycolic acid)) nanoparticles are among the most extensively studied carriers for peptide delivery. This biodegradable copolymer undergoes hydrolytic degradation to lactic and glycolic acid, both endogenous metabolites. Peptide-loaded PLGA nanoparticles can be fabricated via nanoprecipitation or double emulsion methods, yielding particles between 100 and 300 nanometers. Encapsulation efficiencies typically range from 40% to 80%, depending on peptide hydrophobicity and polymer molecular weight. Release profiles exhibit biphasic behavior: an initial burst from surface-associated peptide followed by sustained release from polymer matrix erosion.

Liposomal Systems

Liposomes composed of phospholipid bilayers offer biocompatible encapsulation for both hydrophilic and hydrophilic peptides. Hydrophilic peptides partition into the aqueous core, while amphipathic peptides associate with the lipid bilayer. PEGylated liposomes extend circulation half-life by reducing opsonization. Temperature-sensitive liposomes release cargo upon local heating, enabling triggered delivery to hyperthermic tumor sites.

Chitosan Carriers

Chitosan, a cationic polysaccharide derived from chitin, forms nanoparticles through ionic gelation with tripolyphosphate. The positive surface charge enhances mucoadhesion and cellular uptake. Chitosan nanoparticles are particularly suited for oral peptide delivery, where they protect cargo from gastric acid and facilitate transepithelial transport via paracellular pathways.

Active Targeting

Surface functionalization with targeting ligands enables receptor-mediated endocytosis at specific cell populations. Folate, transferrin, and cyclic RGD peptides are commonly conjugated to nanoparticle surfaces. Stimuli-responsive systems incorporating pH-sensitive polymers, redox-cleavable disulfide bonds, or enzyme-cleavable peptide sequences enable site-specific payload release within intracellular compartments.

Clinical Translation

Despite promising preclinical data, clinical translation of peptide-loaded nanoparticles remains challenging. Reproducible large-scale manufacturing, batch-to-batch consistency, and regulatory standardization of nanomedicine products continue to require resolution.